Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 CSF complements serum for evaluating paraneoplastic antibodies and NMO-IgG.

Literature DB >> 21422462

CSF complements serum for evaluating paraneoplastic antibodies and NMO-IgG.

Andrew McKeon¹, Sean J Pittock, Vanda A Lennon.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2011 PMID： 21422462 PMCID： PMC3270330 DOI： 10.1212/WNL.0b013e318211c379

Source DB: PubMed Journal: Neurology ISSN： 0028-3878 Impact factor: 9.910

× No keyword cloud information.

6 in total

1. NMO-IgG detected in CSF in seronegative neuromyelitis optica.

Authors: E C Klawiter; E Alvarez; J Xu; A R Paciorkowski; L Zhu; B J Parks; A H Cross; R T Naismith
Journal: Neurology Date: 2009-03-24 Impact factor: 9.910

2. Anti-N-methyl-D-aspartate receptor encephalitis during pregnancy.

Authors: Monisha A Kumar; Ankit Jain; Valerie E Dechant; Tsukasa Saito; Timothy Rafael; Hitoshi Aizawa; Kevin C Dysart; Takayuki Katayama; Yasuo Ito; Nobuo Araki; Tatsuya Abe; Rita Balice-Gordon; Josep Dalmau
Journal: Arch Neurol Date: 2010-07

3. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis.

Authors: Vanda A Lennon; Dean M Wingerchuk; Thomas J Kryzer; Sean J Pittock; Claudia F Lucchinetti; Kazuo Fujihara; Ichiro Nakashima; Brian G Weinshenker
Journal: Lancet Date: 2004 Dec 11-17 Impact factor: 79.321

4. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.

Authors: Josep Dalmau; Amy J Gleichman; Ethan G Hughes; Jeffrey E Rossi; Xiaoyu Peng; Meizan Lai; Scott K Dessain; Myrna R Rosenfeld; Rita Balice-Gordon; David R Lynch
Journal: Lancet Neurol Date: 2008-10-11 Impact factor: 44.182

5. Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome.

Authors: Sean J Pittock; Thomas J Kryzer; Vanda A Lennon
Journal: Ann Neurol Date: 2004-11 Impact factor: 10.422

6. Positron emission tomography-computed tomography in paraneoplastic neurologic disorders: systematic analysis and review.

Authors: Andrew McKeon; Metha Apiwattanakul; Daniel H Lachance; Vanda A Lennon; Jayawant N Mandrekar; Bradley F Boeve; Brian Mullan; Bahram Mokri; Jeffrey W Britton; Daniel A Drubach; Sean J Pittock
Journal: Arch Neurol Date: 2010-01-11

6 in total

21 in total

Review 1. Aquaporin 4 and neuromyelitis optica.

Authors: Marios C Papadopoulos; A S Verkman
Journal: Lancet Neurol Date: 2012-05-16 Impact factor: 44.182

2. Autoimmune Encephalitis in the ICU: Analysis of Phenotypes, Serologic Findings, and Outcomes.

Authors: Manoj K Mittal; Alejandro A Rabinstein; Sara E Hocker; Sean J Pittock; Eelco F M Wijdicks; Andrew McKeon
Journal: Neurocrit Care Date: 2016-04 Impact factor: 3.210

Review 3. Neuromyelitis optica spectrum disorders.

Authors: Eoin P Flanagan; Brian G Weinshenker
Journal: Curr Neurol Neurosci Rep Date: 2014-09 Impact factor: 5.081

4. Evaluation of aquaporin-4 antibody assays.

Authors: Patrick J Waters; Sean J Pittock; Jeffrey L Bennett; Sven Jarius; Brian G Weinshenker; Dean M Wingerchuk
Journal: Clin Exp Neuroimmunol Date: 2014-04-22

5. Jasmine smell hides an unwelcome surprise: a case of paraneoplastic limbic encephalitis presenting with olfactory epileptic auras.

Authors: Giovanni Stefanoni; A Formenti; L Tremolizzo; P Remida; C Ferrarese; I Appollonio
Journal: Neurol Sci Date: 2017-03-15 Impact factor: 3.307

6. DPPX potassium channel antibody: frequency, clinical accompaniments, and outcomes in 20 patients.

Authors: William Oliver Tobin; Vanda A Lennon; Lars Komorowski; Christian Probst; Stacey Lynn Clardy; Allen J Aksamit; Juan Pablo Appendino; Claudia F Lucchinetti; Joseph Y Matsumoto; Sean J Pittock; Paola Sandroni; Maja Tippmann-Peikert; Elaine C Wirrell; Andrew McKeon
Journal: Neurology Date: 2014-10-15 Impact factor: 9.910

7. Antibody-Negative Paraneoplastic Limbic Encephalitis, Parkinsonism, Hypothermia, and Narcolepsy Associated with Endometrial Carcinoma.

Authors: Declan Brennan; Olwen C Murphy; Conor Fearon; Francesca Brett; Brian Murray; Tim Lynch
Journal: Mov Disord Clin Pract Date: 2020-01-07